The USP General Chapters—Packaging and Distribution Expert Committee posted a Notice of Intent to Revise on March 31, 2017.
The Packaging and Distribution Expert Committee informed to revise the following four General Chapters:
The Expert Committee says that "the purpose of the revisions will be to provide a three-year period for implementation of the requirements specified in General Chapters <661.1> and <661.2>, which otherwise will become applicable on May 1, 2017 through General Chapter <659>; to reinstate requirements previously expressed in General Chapter <661> during this three-year period; to enable early adoption of the requirements in General Chapters <661.1> and <661.2> at any time during the three-year period in lieu of meeting the reinstated <661> requirements; and to remove the exemption to General Chapters <661.1> for previously approved packaging systems."
The specific intended revisions are as follows:
The new General Chapters <661.1> and <661.2> have become official in May 2016. They have been highly discussed due to the new requirement for <87> Biological Reactivity Tests, In Vitro testing for packaging materials and systems for oral and topical dosage forms. Revised versions of the two chapters have been published for comment in Pharmacopeial Forum 42(4) [Jun-Jul 2016]. With the revision the USP expert committee proposed to delete the requirement to test packaging materials and systems for oral and topical dosage forms according to <87>. Now, the implementation of the new requirements is delayed but not deleted.
The USP states that the proposed revisions to the above-mentioned general chapters will be published as Revision Bulletins on Friday, April 28, 2017 and will become official on May 1, 2017, superseding all previously published revisions. Read more on the USP website.